Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also…
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease…
ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque psoriasis and…
World-leading authorities explore the potential for extending human lifespan on Monday, March 10 at the JW Marriott AustinAUSTIN, Texas, March 07,…
ALBANY, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization,…
SOUTH SAN FRANCISCO, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company…
WOKING, United Kingdom, March 7, 2025 /PRNewswire/ -- IDBS, a leading global provider of cloud software for BioPharma companies, is…
DELRAY BEACH, Fla., March 7, 2025 /PRNewswire/ -- The global Pharmacy Automation Market, valued at US$6.23 billion in 2023, is…
TEMPE, Ariz., March 7, 2025 /PRNewswire/ -- Economic activity in the hospital subsector grew in February for the 18th consecutive month…
TAMPA, Fla., March 7, 2025 /PRNewswire/ -- As Obesity Care Week (OCW) 2025 comes to a close, organizers and supporters…